United Kingdom Home Healthcare Market Size, Share, and COVID-19 Impact Analysis, By Product (Mobility Care Items, Therapeutic Products, and Products for Testing, Screening, and Monitoring), By Service (Skilled Nursing, Rehabilitation Therapy, Hospice and Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy, and Pregnancy Care), and By Indication (Cardiovascular Disorder & Hypertension, Diabetes & Kidney Disorders, Neurological & Mental Disorders, Respiratory Disease & COPD, Maternal Disorders, Mobility Disorders, Cancer, Wound Care, and Others), and United Kingdom Home Healthcare Market Insights, Industry Trend, Forecasts to 2033
Industry: HealthcareUnited Kingdom Home Healthcare Market Insights Forecasts to 2033
- The United Kingdom Home Healthcare Market Size was valued at USD 1.55 Billion in 2023.
- The Market Size is Growing at a CAGR of 7.85% from 2023 to 2033
- The UK Home Healthcare Market Size is expected to reach USD 3.30 Billion by 2033
Get more details on this report -
The United Kingdom Home Healthcare Market Size is anticipated to exceed USD 3.30 Billion by 2033, Growing at a CAGR of 7.85% from 2023 to 2033.
The growing aging population with the increasing prevalence of chronic diseases, that can be taken care of at home and the need for cost-effective care solutions are driving the growth of the home healthcare market in the United Kingdom.
Market Overview
Home healthcare is a healthcare service that can be given at home for an injury or illness. Home healthcare is augmenting healthcare services for older people at their greater independence in a convenient, safe, and comfortable way. It also aids in preventing avoidable trips to the hospital. Home patient care offers a range of benefits, including the preservation of a familiar environment, reduced healthcare costs, and the ability to receive personalized attention. These solutions are evolving towards proactive, data-driven models, focusing on personalized, preventive care and enhanced patient engagement and education. Further, the integration of cutting-edge technology like IoT devices enables real-time health monitoring and predictive analytics. Telehealth is one of the growth opportunities in remote consultations and monitoring, enhancing patient accessibility and convenience. AI is the game changer that promises improved diagnosis and treatment, balancing technology with human empathy, and enhancing patient care with the help of personalized treatment strategy and early disease detection. Home healthcare is significantly reducing hospital readmissions and long-term care expenses and thus is cost-effective. This sector is witnessing robust growth, driven by technological advancements and an aging population. Investors are keenly eyeing this sector, recognizing substantial opportunities in innovative home care solutions and services.
Report Coverage
This research report categorizes the market for the UK home healthcare market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the home healthcare market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the home healthcare market.
United Kingdom Home Healthcare Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2023 |
Market Size in 2023: | USD 1.55 Billion |
Forecast Period: | 2023 - 2033 |
Forecast Period CAGR 2023 - 2033 : | 7.85% |
2033 Value Projection: | USD 3.30 Billion |
Historical Data for: | 2019 - 2022 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 110 |
Segments covered: | By Product, By Service, By Indication |
Companies covered:: | B. Braun SE, Coloplast Corp, Smith+Nephew, Medline Industries, Fresenius Medical Care AG & Co. KGaA, Holister Incorporated, Convatec Group PLC, Molnlycke Helth Care AB, 3M, Care UK, and Others |
Pitfalls & Challenges: | COVID-19 Empact, Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
Over 11 million which is 18.6% of the total population in the UK are having age more than 65 years according to National Statistics in 2022. Thus, the growing geriatric population suffering from various chronic diseases such as incontinence, ostomy, and diabetic foot ulcer drives the market growth in the UK. The rising need for cost-effective care solutions is expected to drive the market demand. Further, rising technological advancement enables less dependence on healthcare professionals and providing healthcare facilities at home. There is a growing inclination/preference towards home healthcare services especially for chronic disease patients as home care services are cheaper than hospital care with reduced risk of infection. These factors are driving the home healthcare market.
Restraining Factors
Psychological abuse, neglectful care practices, and other potential gaps are responsible for restraining the home healthcare market.
Market Segmentation
The United Kingdom Home Healthcare Market share is classified into product, service, and indication.
- The therapeutic products segment accounted for the largest market share in 2023.
The United Kingdom home healthcare market is segmented by product into mobility care items, therapeutic products, and products for testing, screening, and monitoring. Among these, the therapeutic products segment accounted for the largest market share in 2023. The rising prevalence of chronic illness including renal diseases, sleep, and respiratory problems, is raising the market demand for home healthcare in the therapeutic products segment.
- The skilled nursing segment dominates the market with a significant market share through the forecast period.
The United Kingdom home healthcare market is segmented by service into skilled nursing, rehabilitation therapy, hospice and palliative care, unskilled care, respiratory therapy, infusion therapy, and pregnancy care. Among these, the skilled nursing segment dominates the market with a significant market share through the forecast period. Quality medical assistance is provided by skilled nurses in their own homes conveniently and comfortably. The skilled nursing segment of home healthcare is usually dominated by geriatric patients.
- The neurological & mental disorders segment accounted for the largest market share in 2023.
The United Kingdom home healthcare market is segmented by indication into cardiovascular disorder & hypertension, diabetes & kidney disorders, neurological & mental disorders, respiratory disease & COPD, maternal disorders, mobility disorders, cancer, wound care, and others. Among these, the neurological & mental disorders segment accounted for the largest market share in 2023. The rising prevalence of neurological disorders, including epilepsy, Alzheimer's & other dementias, stroke, migraine & other headaches, multiple sclerosis, and Parkinson's disease are driving the market demand in the neurological & mental disorders segment. Alzheimer's disease is the most common cause of death in neurodegenerative diseases.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the UK home healthcare market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- B. Braun SE
- Coloplast Corp
- Smith+Nephew
- Medline Industries
- Fresenius Medical Care AG & Co. KGaA
- Holister Incorporated
- Convatec Group PLC
- Molnlycke Helth Care AB
- 3M
- Care UK
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In December 2022, Nurseplus launched the ‘Care at home’ service in Aylesbury.
- In June 2021, Ontex, a Belgium-based international personal hygiene group developed a smart continence management service for care homes and hospitals in Europe under the brand Orizon.
Market Segment
This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the United Kingdom Home Healthcare Market based on the below-mentioned segments:
United Kingdom Home Healthcare Market, By Product
- Mobility Care Items
- Therapeutic Products
- Products for Testing, Screening, and Monitoring
United Kingdom Home Healthcare Market, By Service
- Skilled Nursing
- Rehabilitation Therapy
- Hospice and Palliative Care
- Unskilled Care
- Respiratory Therapy
- Infusion Therapy
- Pregnancy Care
United Kingdom Home Healthcare Market, By Indication
- Cardiovascular Disorder & Hypertension
- Diabetes & Kidney Disorders
- Neurological & Mental Disorders
- Respiratory Disease & COPD
- Maternal Disorders
- Mobility Disorders
- Cancer
- Wound Care
- Others
Need help to buy this report?